Organization
Palatin Technologies Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Palatin Technologies Inc.
... Palatin Technologies, Inc., a biopharmaceutical company, reported net loss of $(0.7) million, or $(0.00) ...
... Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ...
... Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2018 ...
... Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ...
... Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ...
... CRANBURY - Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ...
... Food and Drug Administration (FDA) for bremelanotide, which AMAG in-licensed from Palatin Technologies, Inc. in February 2017. Bremelanotide is a first-in-class melanocortin 4 receptor agonist ...
... Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ...
... WallStEquities.com observes the recent performance of Atossa Genetics Inc. (NASDAQ: ATOS), Palatin Technologies Inc. (NYSEAMER: PTN), Adamis Pharmaceuticals Corp. (NASDAQ: ADMP), and Perrigo Co. PLC ...
Subscribe now for full coverage on Palatin Technologies Inc.
Start My Free Trial